Doctors Note Logo

Published on: 9/24/2026

What are the side effects of the Wegovy pill?

The oral form of Wegovy (semaglutide) most often causes digestive side effects, including nausea, vomiting, diarrhea, constipation, stomach pain, indigestion, burping, gas, headache, fatigue, and dizziness, which tend to be strongest when starting the drug or increasing the dose. Less common but serious risks include pancreatitis, gallbladder disease and gallstones, kidney injury from dehydration, low blood sugar (especially with insulin or sulfonylureas), vision changes linked to diabetic retinopathy, fast heart rate, allergic reactions, and a boxed warning about thyroid C-cell tumors seen in rodent studies. Mood changes or thoughts of self-harm have also been reported and should be discussed with a clinician right away. Who should avoid it, how side effects differ from the injection, and which symptoms signal an emergency are important factors to weigh, so see below to understand more.

If your stomach pain, nausea, or other symptoms feel more intense than expected, it can be hard to tell whether your body is simply adjusting or something more serious is developing, and a free, instant, online symptom check can help you sort possible causes and decide whether to call your prescriber, seek urgent care, or keep monitoring at home.

Last reviewed for medical accuracy: 09/24/2026

answer background

Explanation

Wegovy (semaglutide) is a prescription medication approved to help with weight management. Though it’s given by injection rather than as a traditional pill, many people refer to it colloquially as the “Wegovy pill.” Like any medicine, it can cause side effects. This guide covers what you need to know in clear, straightforward language—without sugar-coating, but also without creating unnecessary worry.

Common (Mild to Moderate) Side Effects
These occur in many people, especially when first starting Wegovy or after a dose increase. They tend to improve over time:

• Nausea
– Often the earliest and most common complaint.
– Usually mild to moderate and decreases after a few weeks.
– Tips: Eat smaller, more frequent meals; avoid high-fat or spicy foods.

• Vomiting
– Less common than nausea but can happen, particularly at higher doses.
– Keep hydrated; if persistent, lower doses or slower dose increases may help.

• Diarrhea
– May lead to dehydration or electrolyte imbalance if severe.
– Drink plenty of fluids; consider bland foods (e.g., bananas, rice, toast).

• Constipation
– Some people swing from diarrhea to constipation.
– Increase fiber intake and water; gentle exercise can help.

• Abdominal (Stomach) Pain or Discomfort
– Cramping, bloating or indigestion (“dyspepsia”) are possible.
– Over-the-counter antacids or simethicone may ease symptoms.

• Injection-Site Reactions
– Redness, itching or swelling where the needle goes in.
– Rotating the injection sites (abdomen, thigh, upper arm) can reduce irritation.

• Headache
– Often mild and transient; over-the-counter pain relievers usually help.

• Fatigue or Tiredness
– May accompany nausea or other GI symptoms; typically resolves as your body adjusts.

Less Common (Potentially Serious) Side Effects
These are less frequent but warrant closer attention. If you notice any of these, talk to your doctor:

• Pancreatitis (Inflammation of the Pancreas)
– Symptoms: Severe, persistent stomach pain (sometimes radiating to the back), nausea/vomiting that won’t go away.
– Action: Stop Wegovy and seek medical care immediately—pancreatitis can be life-threatening.

• Gallbladder Disease
– Rapid weight loss can trigger gallstones or inflammation of the gallbladder.
– Symptoms: Sharp pain in the right upper abdomen, nausea, fever, yellowing of skin/eyes.
– Action: See your doctor or emergency care if you develop these symptoms.

• Kidney Injury or Dehydration
– Severe vomiting or diarrhea can lead to dehydration, which in turn may affect kidney function.
– Symptoms: Reduced urine output, dizziness, extreme thirst.
– Action: Rehydrate promptly; call your doctor if you can’t keep fluids down.

• Hypoglycemia (Low Blood Sugar)
– More likely if you’re also on insulin or other diabetes medications.
– Symptoms: Shakiness, sweating, confusion, rapid heartbeat.
– Action: Carry fast-acting carbs (glucose tablets, juice) and check with your doctor about adjusting other meds.

• Increased Heart Rate
– Some people notice a faster resting heartbeat.
– Usually mild, but persistent palpitations or dizziness deserve medical evaluation.

Rare but Serious Side Effects
Though uncommon, these require urgent attention:

• Medullary Thyroid Carcinoma (MTC)
– Animal studies showed a risk of thyroid C-cell tumors; human risk is unknown but considered low.
– Warning signs: A lump in the neck, difficulty swallowing or breathing, hoarseness.
– Action: Inform your doctor if you have a personal/family history of thyroid cancer or MEN2 syndrome.

• Suicidal Thoughts or Mood Changes
– Any new or worsening depression, anxiety or thoughts of self-harm should prompt immediate discussion with a healthcare professional.

Warnings and Precautions
Before starting Wegovy, discuss the following with your doctor:

• Personal or Family History of Medullary Thyroid Carcinoma (MTC) or MEN2
• History of Pancreatitis or Gallbladder Disease
• Severe Gastrointestinal Problems (e.g., gastroparesis, inflammatory bowel disease)
• Existing Kidney or Liver Impairment
• Current Use of Insulin or Certain Diabetes Medications
• Pregnancy or Breastfeeding (safety not established)

Tips to Manage Side Effects
• Start Low, Go Slow: Your prescriber will usually begin at 0.25 mg once weekly and gradually increase over months.
• Stay Hydrated: Sip water throughout the day, especially if you experience vomiting or diarrhea.
• Mind Your Diet: Eat small meals, avoid fatty or spicy foods, and include gentle, easy-to-digest options.
• Rotate Injection Sites: Give your skin a break by changing the injection area each week.
• Track Your Symptoms: Keeping a simple diary can help you and your doctor pinpoint triggers or patterns.
• Use Over-the-Counter Aids Wisely: Antacids, stool softeners or antiemetics can be helpful under your doctor’s guidance.

When to Seek Help
• Severe Abdominal Pain or Persistent Vomiting
• Signs of Dehydration (dizziness, low urine output)
• Symptoms of Pancreatitis, Gallstones or Thyroid Issues
• New or Worsening Mood Changes
• Hypoglycemia That Doesn’t Improve with Fast-Acting Sugars

If you’re unsure whether your symptoms are serious, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide if you need to see a healthcare professional right away.

Final Thoughts
Wegovy can be an effective aid in weight management, but it isn’t without potential side effects. Many people tolerate it well once their bodies adjust, while others may need extra support or an alternative approach. Always keep an open line of communication with your healthcare provider. If you experience anything that feels life-threatening or unusually severe, stop the medication and seek medical care immediately.

Speak to your doctor about any concerns or persistent symptoms to ensure you’re using Wegovy safely and effectively.

(References)

  • * Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T, SUSTAIN-6 Investigators. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. PMID: 27633186.

  • * Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I, STEP 2 Study Group. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021 Mar 13;397(10278):971-984. doi: 10.1016/S0140-6736(21)00213-0. Epub 2021 Mar 2. PMID: 33667417.

  • * Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D, STEP 4 Investigators. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021 Apr 13;325(14):1414-1425. doi: 10.1001/jama.2021.3224. PMID: 33755728; PMCID: PMC7988425.

  • * Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, Fernández Landó L, Bergman BK, Liu B, Cui X, Brown K, SURPASS-2 Investigators. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.

  • * Smits MM, Van Raalte DH. Safety of Semaglutide. Front Endocrinol (Lausanne). 2021;12:645563. doi: 10.3389/fendo.2021.645563. Epub 2021 Jul 7. PMID: 34305810; PMCID: PMC8294388.

  • * Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends Cardiovasc Med. 2023 Apr;33(3):159-166. doi: 10.1016/j.tcm.2021.12.008. Epub 2021 Dec 21. PMID: 34942372; PMCID: PMC9209591.

  • * Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Wharton S, STEP 5 Study Group. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022 Oct;28(10):2083-2091. doi: 10.1038/s41591-022-02026-4. Epub 2022 Oct 10. PMID: 36216945; PMCID: PMC9556320.

  • * Tan HC, Dampil OA, Marquez MM. Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis. J ASEAN Fed Endocr Soc. 2022;37(2):65-72. doi: 10.15605/jafes.037.02.14. Epub 2022 Aug 23. PMID: 36578889; PMCID: PMC9758543.

  • * Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH, SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. PMID: 37952131.

  • * Garvey WT, Blüher M, Osorto Contreras CK, Davies MJ, Winning Lehmann E, Pietiläinen KH, Rubino D, Sbraccia P, Wadden T, Zeuthen N, Wilding JPH, REDEFINE 1 Study Group. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025 Aug 14;393(7):635-647. doi: 10.1056/NEJMoa2502081. Epub 2025 Jun 22. PMID: 40544433.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.